Importance of Long-Term Data in Plaque Psoriasis
Leon Kircik, MD, shares his impressions of the long-term data of roflumilast, and where it fits into clinical practice.
Long-Term Safety and Efficacy of Roflumilast Cream in Plaque Psoriasis
Leon Kircik, MD, reviews a recent study of roflumilast and its long-term efficacy and safety data in chronic plaque psoriasis.
Roflumilast Clinical Development Program in Plaque Psoriasis
Leon Kircik, MD, discusses the recent FDA approval of roflumilast for plaque psoriasis treatment.
PDE4 in Plaque Psoriasis
Leon Kircik, MD, provides an overview of PDE4 inhibitors in the treatment of plaque psoriasis.
Atopic Dermatitis: An Evolving Treatment Landscape
Closing out its discussion on atopic dermatitis, the panel considers best practices and unmet needs in the treatment landscape.
When to Change Therapy for Atopic Dermatitis
A brief discussion on when it is best to switch therapy while treating patients for atopic dermatitis.
Atopic Dermatitis: Systemic Therapy Armamentarium
Shared insight on the armamentarium of systemic agents available to treat atopic dermatitis.
Topical Calcineurin and PDE-4 Inhibitors in the Treatment of AD
A review of topical therapies that have been long utilized for patients with atopic dermatitis.
Atopic Dermatitis: Patient Factors in Selecting Therapy
A brief review of patient and disease factors that inform selection of therapy for atopic dermatitis.
Nonpharmacological Approaches to Managing Atopic Dermatitis
Expert insight on nonpharmacological strategies to treat atopic dermatitis and improve patient quality of life.
Concomitant Use of JAK Inhibitors in Atopic Dermatitis
A brief evaluation of the concomitant use of JAK inhibitors, topical or systemic, in patients with atopic dermatitis.
Systemic JAK Inhibition in Atopic Dermatitis Care Strategies
Switching its focus to systemic JAK inhibitors, the panel reviews real-world use of available agents to treat patients with atopic dermatitis.
Topical JAK Inhibition in Atopic Dermatitis Care Strategies
The panelists discuss real-world use of topical ruxolitinib in atopic dermatitis management given safety, efficacy, and availability.
Atopic Dermatitis: Clinical Trials With Topical Ruxolitinib
Considerations for topical ruxolitinib with deference to positive clinical trial results in atopic dermatitis.
An Overview of JAK Inhibition in Atopic Dermatitis
Shared insight on the available JAK inhibitors for atopic dermatitis, both topical and systemic.
Identifying Comorbidities Associated With Atopic Dermatitis
Experts reflect on the various comorbid conditions associated with atopic dermatitis and how they can affect patients.
What is the Burden of Atopic Dermatitis?
Comprehensive discussion on how atopic dermatitis can impact a patient’s quality of life.
Persistent Atopic Dermatitis and Flare-ups
Considerations for persistent atopic dermatitis vs outgrowing disease, followed by triggers that can result in flare-ups.
Understanding Patient Presentations With Atopic Dermatitis
Shared insight on the ways a child or adult may present with atopic dermatitis.
The Pathophysiology of Atopic Dermatitis
A panel of experts review the pathophysiology of atopic dermatitis and its contributing factors.
2 Clarke Drive Cranbury, NJ 08512